Search Results - "Dutra, Jessyca Aparecida Paes"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1
  2. 2

    Highlights in targeted nanoparticles as a delivery strategy for glioma treatment by Luiz, Marcela Tavares, Delello Di Filippo, Leonardo, Tofani, Larissa Bueno, de Araújo, Jennifer Thayanne Cavalcante, Dutra, Jessyca Aparecida Paes, Marchetti, Juliana Maldonado, Chorilli, Marlus

    Published in International journal of pharmaceutics (15-07-2021)
    “…[Display omitted] Glioma is the most common type of Central Nervous System (CNS) neoplasia and it arises from glial cells. As glial cells are formed by…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy by Luiz, Marcela Tavares, Dutra, Jessyca Aparecida Paes, Tofani, Larissa Bueno, de Araújo, Jennifer Thayanne Cavalcante, Di Filippo, Leonardo Delello, Marchetti, Juliana Maldonado, Chorilli, Marlus

    Published in Pharmaceutics (08-04-2022)
    “…Cancer is the second most frequent cause of death worldwide, with 28.4 million new cases expected for 2040. Despite de advances in the treatment, it remains a…”
    Get full text
    Journal Article
  5. 5

    Epirubicin: Biological Properties, Analytical Methods, and Drug Delivery Nanosystems by Luiz, Marcela Tavares, Dutra, Jessyca Aparecida Paes, Di Filippo, Leonardo Delello, Junior, Alberto Gomes Tavares, Tofani, Larissa Bueno, Marchetti, Juliana Maldonado, Chorilli, Marlus

    “…Epirubicin (EPI) is a chemotherapeutic agent belonging to the anthracycline drug class indicated for treating several tumors. It acts by suppressing the DNA…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Hybrid Magnetic Lipid-Based Nanoparticles for Cancer Therapy by Luiz, Marcela Tavares, Dutra, Jessyca Aparecida Paes, Viegas, Juliana Santos Rosa, de Araújo, Jennifer Thayanne Cavalcante, Tavares Junior, Alberto Gomes, Chorilli, Marlus

    Published in Pharmaceutics (23-02-2023)
    “…Cancer is one of the major public health problems worldwide. Despite the advances in cancer therapy, it remains a challenge due to the low specificity of…”
    Get full text
    Journal Article
  9. 9

    A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas by Di Filippo, Leonardo Delello, de Carvalho, Suzana Gonçalves, Duarte, Jonatas Lobato, Luiz, Marcela Tavares, Paes Dutra, Jessyca Aparecida, de Paula, Geanne Aparecida, Chorilli, Marlus, Conde, João

    Published in Materials today bio (01-06-2023)
    “…Gliomas are the most common type of brain cancer, and among them, glioblastoma multiforme (GBM) is the most prevalent (about 60% of cases) and the most…”
    Get full text
    Journal Article
  10. 10

    Three-dimensional culture models: emerging platforms for screening the antitumoral efficacy of nanomedicines by Tofani, Larissa Bueno, Luiz, Marcela Tavares, Paes Dutra, Jessyca Aparecida, Abriata, Juliana Palma, Chorilli, Marlus

    Published in Nanomedicine (London, England) (01-03-2023)
    “…Nanomedicines have been investigated for delivering drugs to tumors due to their ability to accumulate in the tumor tissues. 2D cell culture has been used to…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Folic acid-modified curcumin-loaded liposomes for breast cancer therapy by Luiz, Marcela Tavares, Dutra, Jessyca Aparecida Paes, Ribeiro, Taís de Cássia, Carvalho, Gabriela Corrêa, Sábio, Rafael Miguel, Marchetti, Juliana Maldonado, Chorilli, Marlus

    “…Breast cancer is the commonest cancer among women, with more than 2 million cases per year and a lethality rate of 17.7%. The treatment of breast cancer still…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    OBTENÇÃO DO EXTRATO DAS FOLHAS DE Croton urucurana Baill. (Euphorbiaceae) E DESENVOLVIMENTO DE EMULSÃO by Paes Dutra, Jessyca Aparecida, Villanova, Janaína Cecília Oliveira, Severi, Juliana Aparecida

    Published in Revista UniVap (02-12-2016)
    “…O uso de fitoterápicos foi incorporado ao Sistema Único de Saúde, por meio do Decreto Nº 5.813, de 22 de junho de 2006 e, nas últimas décadas, o interesse da…”
    Get full text
    Journal Article